Tecan Group AG
Company Profile
Business description
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
Contact
Seestrasse 103
Mannedorf8708
CHET: +41 449228111
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
3,305
Stocks News & Analysis
stocks
ASX listed bank overvalued despite strong earnings
stocks
After earnings, is Amazon a buy, a sell, or fairly valued?
stocks
ASX retail share expected to recover despite choppy conditions
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,942.40 | 14.50 | 0.16% |
| CAC 40 | 8,056.38 | 56.19 | -0.69% |
| DAX 40 | 24,355.41 | 16.78 | 0.07% |
| Dow JONES (US) | 49,604.28 | 4.88 | -0.01% |
| FTSE 100 | 10,269.43 | 36.36 | 0.36% |
| HKSE | 26,406.84 | 13.13 | 0.05% |
| NASDAQ | 26,327.46 | 80.38 | 0.31% |
| Nikkei 225 | 62,417.88 | 295.77 | -0.47% |
| NZX 50 Index | 13,210.48 | 35.35 | 0.27% |
| S&P 500 | 7,420.43 | 21.50 | 0.29% |
| S&P/ASX 200 | 8,701.80 | 11.50 | 0.13% |
| SSE Composite Index | 4,225.02 | 45.07 | 1.08% |